CollPlant Biotechnologies Ltd (CLGN) Operating income 2018–2025
CollPlant Biotechnologies Ltd (CLGN) annual operating income history from SEC filings — each fiscal year as reported.
-$11.5MFY2025 · since FY2018: -$4.2M → -$11.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.5M | +33.4% |
| FY2024 | -$17.3M | -129.6% |
| FY2023 | -$7.5M | +56.1% |
| FY2022 | -$17.1M | -26403.1% |
| FY2021 | $65,000 | +101.2% |
| FY2020 | -$5.6M | +26.6% |
| FY2019 | -$7.6M | -79.8% |
| FY2018 | -$4.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLGN financial trends
CLGN RevenueCLGN Net incomeCLGN Net marginCLGN Gross profitCLGN Gross marginCLGN Operating marginCLGN Operating cash flowCLGN Free cash flowCLGN Capital expendituresCLGN Return on equityCLGN Stock buybacksCLGN Dividends paidCLGN Total assetsCLGN Total liabilitiesCLGN Shareholders’ equityCLGN overview →